The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine
Clinical trial NCT00216606 · COMPLETED
Trial details
- NCT number
- NCT00216606
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.